CORRIE BAKER: Open Payments
NPI 1376237941 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,041 in 31 payments from 14 companies in 2025. Trend: 2023 $344 · 2024 $1,045 · 2025 $2,041
Food & beverage: $2,041
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $410 |
| Madrigal Pharmaceuticals | 4 | $333 |
| Mallinckrodt Hospital Products Inc. | 6 | $220 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $168 |
| Medtronic, Inc. | 1 | $163 |
| Boston Scientific Corporation | 2 | $148 |
| Gilead Sciences, Inc. | 1 | $119 |
| Ardelyx, Inc. | 1 | $116 |
| Regeneron Healthcare Solutions, Inc. | 1 | $108 |
| Amgen Inc. | 1 | $91 |
Products named: REZDIFFRA, TERLIVAZ, XIFAXAN, GI GENIUS, RINVOQ, EXALT Model D, Livdelzi, IBSRELA.
Industry payments across FL — which companies pay providers there.
